Clinical Trial Update: Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing repaglinide/metformin versus rosiglitazone/metformin fixed-dose combinations for blood glucose control in type 2 diabetes; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Repaglinide (Repaglinide)
• Rosiglitazone (rosiglitazone)
• metformin (metformin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED